DRUG

Bright Minds Biosciences Inc. NASDAQ Listed Mar 22, 2021

Healthcare ·Biotechnology ·CA · brightmindsbio.com

$60.66

+1.92% vs $59.52

Mkt Cap $417.2M

52w Low $23.27 51.4% of range 52w High $95.99

50d MA $80.54 200d MA $72.82

P/E (TTM) -34.1x

EV/EBITDA —

P/B 5.1x

Debt/Equity 0.0x

ROE —

P/FCF -48.0x

RSI (14) 12.20

ATR (14) $5.17

Beta -0.11

50d MA $80.54

200d MA $72.82

Avg Volume 374.5K

Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was incorporated in 2019 and is headquartered in Vancouver, Canada.

SIC Code

2834

CIK (SEC)

1827401

Phone

647 407 2515

1500 – 1055 West Georgia Street · New York City, BC V6E 4N7 · CA

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
May 19, 2026	AMC	-0.92	-0.80	+12.7%	74.54	+3.3%	+11.1%	+0.6%	+0.3%	+3.3%	+0.9%	—
Feb 12, 2026	AMC	-0.98	-0.70	+28.6%	80.57	+0.3%	-3.3%	+7.7%	-4.3%	+7.2%	-0.7%	—
Dec 23, 2025	AMC	-0.56	-0.41	+27.1%	84.27	+0.5%	+0.5%	-3.0%	-4.9%	-2.9%	+2.9%	—
Aug 14, 2025	AMC	-0.59	-0.53	+10.2%	42.54	+2.1%	-1.7%	+8.9%	-6.4%	+0.9%	-2.1%	—
Feb 13, 2025	AMC	-0.23	0.01	+104.3%	45.72	-1.7%	-8.6%	-10.3%	-0.3%	-3.3%	-0.4%	—
Dec 30, 2024	AMC	-0.44	-0.12	+72.9%	36.86	+2.3%	-2.3%	+14.1%	-3.1%	+3.9%	-2.9%	—
Aug 14, 2024	AMC	—	0.04	—	1.01	+4.0%	+2.0%	+3.9%	-4.7%	-1.0%	+2.0%	—
May 15, 2024	AMC	—	-0.10	—	1.09	+0.9%	-2.8%	+3.8%	-0.9%	+11.9%	-7.4%	—
Feb 12, 2024	AMC	—	-0.32	—	1.90	+4.2%	+1.6%	+1.6%	+0.0%	-0.5%	-4.1%	—
Dec 29, 2023	AMC	—	-0.30	—	1.43	+4.2%	+28.7%	-9.2%	+2.4%	-0.6%	+10.6%	—
Aug 14, 2023	AMC	—	-0.29	—	2.42	-2.5%	+9.5%	-2.6%	-0.4%	+2.3%	-0.8%	—
May 15, 2023	AMC	—	-0.08	—	2.70	+0.4%	+4.4%	-1.1%	-6.5%	-3.1%	+1.6%	—
Feb 7, 2023	AMC	—	-0.10	—	4.10	-1.7%	-4.9%	-6.4%	+2.7%	-1.1%	+0.5%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Mar 30	BTIG	Maintains	Buy → Buy	—	$70.10	$70.89	+1.1%	-2.4%	+6.6%	-1.7%	-0.4%	+4.9%
Mar 4	HC Wainwright & Co.	Maintains	Buy → Buy	—	$80.00	$80.00	+0.0%	-0.9%	-1.9%	-1.2%	+4.7%	-1.0%
Feb 17	BTIG	Maintains	Buy → Buy	—	$77.90	$77.60	-0.4%	+7.7%	-4.3%	+7.2%	-0.7%	+1.2%
Jan 7	BTIG	Maintains	Buy → Buy	—	$93.21	$91.64	-1.7%	+3.0%	-6.2%	-3.6%	+2.2%	+0.8%
Jan 6	BTIG	Maintains	Buy → Buy	—	$80.01	$119.80	+49.7%	+16.5%	+3.0%	-6.2%	-3.6%	+2.2%
Jan 2	Chardan Capital	Maintains	Buy → Buy	—	$78.04	$79.51	+1.9%	+6.9%	-4.1%	+16.5%	+3.0%	-6.2%
Dec 30	HC Wainwright & Co.	Maintains	Buy → Buy	—	$78.12	$78.26	+0.2%	-2.9%	+2.9%	+6.9%	-4.1%	+16.5%
Sep 15	HC Wainwright & Co.	Maintains	Buy → Buy	—	$48.75	$48.80	+0.1%	-0.2%	-6.6%	-1.7%	+12.2%	+6.2%
Aug 19	HC Wainwright & Co.	Maintains	Buy → Buy	—	$45.55	$46.13	+1.3%	-6.4%	+0.9%	-2.1%	+4.3%	-5.1%
May 21	Chardan Capital	Maintains	Buy → Buy	—	$32.46	$32.10	-1.1%	-6.3%	-0.7%	-4.0%	-5.4%	-0.3%
Feb 19	HC Wainwright & Co.	Maintains	Buy → Buy	—	$37.51	$37.07	-1.2%	-0.3%	-3.3%	-0.4%	-0.1%	-5.3%

Date	Insider	Title	Type	Shares	Price	Value	Owned After	D1%	D5%
Apr 28, 2026	Cormorant Asset Management, LP	—	Sell	109,331	$89.50	$9.8M	950,000	-1.13%	+0.09%

Institutional (13F) — Top 0 All ↗

No 13F holders found.

Mutual Funds / ETFs (N-PORT) — Top 9 All ↗

#	Fund	Shares	Value	Period
1	BlackRock Health Sciences Opportunities Portfolio	95,655	$8M	Feb 2026
2	Adara Smaller Companies Fund	20,238	$2M	Feb 2026
3	AdvisorShares Psychedelics ETF	12,613	$920K	Mar 2026
4	Goldman Sachs Small Cap Growth Insights Fund	3,458	$269K	Jan 2026
5	Goldman Sachs Small Cap Equity Insights Fund	3,139	$244K	Jan 2026
6	Small Cap Index Fund	3,289	$240K	Mar 2026
7	Penn Series Small Cap Index Fund	100	$7K	Mar 2026
8	Russell 2000 Fund	16	$1K	Mar 2026
9	Russell 2000 1.5x Strategy Fund	9	$657	Mar 2026

Data updated apr 25, 2026 5:48am · Source: financialmodelingprep.com